CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-011381
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Exosome complex component RRP45 
Protein Synonyms/Alias
 Autoantigen PM/Scl 1; Exosome component 9; P75 polymyositis-scleroderma overlap syndrome-associated autoantigen; Polymyositis/scleroderma autoantigen 1; Polymyositis/scleroderma autoantigen 75 kDa; PM/Scl-75 
Gene Name
 EXOSC9 
Gene Synonyms/Alias
 PMSCL1 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
2******MKETPLSNCubiquitination[1]
52CCIVELGKTRVLGQVubiquitination[1, 2]
67SCELVSPKLNRATEGubiquitination[1]
101RQSDLLVKLNRLMERubiquitination[1]
114ERCLRNSKCIDTESLubiquitination[1]
257CSKIAGVKVAEITELubiquitination[1]
267EITELILKALENDQKubiquitination[1]
274KALENDQKVRKEGGKubiquitination[1]
277ENDQKVRKEGGKFGFubiquitination[1]
281KVRKEGGKFGFAESIubiquitination[1, 2]
297NQRITAFKMEKAPIDubiquitination[1]
300ITAFKMEKAPIDTSDubiquitination[1]
Reference
 [1] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
 Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
 Mol Cell Proteomics. 2013 Mar;12(3):825-31. [PMID: 23266961]
 [2] Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.
 Udeshi ND, Mani DR, Eisenhaure T, Mertins P, Jaffe JD, Clauser KR, Hacohen N, Carr SA.
 Mol Cell Proteomics. 2012 May;11(5):148-59. [PMID: 22505724
Functional Description
 Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC9 binds to ARE-containing RNAs. 
Sequence Annotation
 REGION 1 268 ARE binding.
 MOD_RES 297 297 N6-acetyllysine.
 MOD_RES 306 306 Phosphoserine.
 MOD_RES 392 392 Phosphoserine.
 MOD_RES 394 394 Phosphoserine.  
Keyword
 3D-structure; Acetylation; Alternative splicing; Complete proteome; Cytoplasm; Exosome; Nucleus; Phosphoprotein; Polymorphism; Reference proteome; RNA-binding; rRNA processing. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 439 AA 
Protein Sequence
MKETPLSNCE RRFLLRAIEE KKRLDGRQTY DYRNIRISFG TDYGCCIVEL GKTRVLGQVS 60
CELVSPKLNR ATEGILFFNL ELSQMAAPAF EPGRQSDLLV KLNRLMERCL RNSKCIDTES 120
LCVVAGEKVW QIRVDLHLLN HDGNIIDAAS IAAIVALCHF RRPDVSVQGD EVTLYTPEER 180
DPVPLSIHHM PICVSFAFFQ QGTYLLVDPN EREERVMDGL LVIAMNKHRE ICTIQSSGGI 240
MLLKDQVLRC SKIAGVKVAE ITELILKALE NDQKVRKEGG KFGFAESIAN QRITAFKMEK 300
APIDTSDVEE KAEEIIAEAE PPSEVVSTPV LWTPGTAQIG EGVENSWGDL EDSEKEDDEG 360
GGDQAIILDG IKMDTGVEVS DIGSQELGFH HVGQTGLEFL TSDAPIILSD SEEEEMIILE 420
PDKNPKKIRT QTTSAKQEKA PSKKPVKRRK KKRAAN 456 
Gene Ontology
 GO:0005829; C:cytosol; TAS:Reactome.
 GO:0000176; C:nuclear exosome (RNase complex); IDA:UniProtKB.
 GO:0005730; C:nucleolus; IDA:UniProtKB.
 GO:0005634; C:nucleus; IDA:UniProtKB.
 GO:0000175; F:3'-5'-exoribonuclease activity; NAS:UniProtKB.
 GO:0017091; F:AU-rich element binding; IDA:UniProtKB.
 GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; IMP:UniProtKB.
 GO:0006955; P:immune response; NAS:UniProtKB.
 GO:0071028; P:nuclear mRNA surveillance; IMP:UniProtKB.
 GO:0071035; P:nuclear polyadenylation-dependent rRNA catabolic process; IMP:UniProtKB.
 GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB.
 GO:0006364; P:rRNA processing; NAS:UniProtKB. 
Interpro
 IPR001247; ExoRNase_PH_dom1.
 IPR015847; ExoRNase_PH_dom2.
 IPR020568; Ribosomal_S5_D2-typ_fold. 
Pfam
 PF01138; RNase_PH
 PF03725; RNase_PH_C 
SMART
  
PROSITE
  
PRINTS